This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2006 Dec 6;296(21):2555; author reply 2555-6.

doi: 10.1001/jama.296.21.2555-a.

Efficacy of varenicline for smoking cessation

Alain Dervaux, Mostafa Kanit, Xavier Laqueille

PMID: 17148718
DOI: 10.1001/jama.296.21.2555-a

Comment

Efficacy of varenicline for smoking cessation

Alain Dervaux et al. JAMA. 2006.

. 2006 Dec 6;296(21):2555; author reply 2555-6.

doi: 10.1001/jama.296.21.2555-a.

Authors

Alain Dervaux, Mostafa Kanit, Xavier Laqueille

PMID: 17148718
DOI: 10.1001/jama.296.21.2555-a

No abstract available

PubMed Disclaimer

Comment on

Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.
Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, Billing CB, Watsky EJ, Gong J, Williams KE, Reeves KR; Varenicline Phase 3 Study Group. Gonzales D, et al. JAMA. 2006 Jul 5;296(1):47-55. doi: 10.1001/jama.296.1.47. JAMA. 2006. PMID: 16820546 Clinical Trial.
Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
Jorenby DE, Hays JT, Rigotti NA, Azoulay S, Watsky EJ, Williams KE, Billing CB, Gong J, Reeves KR; Varenicline Phase 3 Study Group. Jorenby DE, et al. JAMA. 2006 Jul 5;296(1):56-63. doi: 10.1001/jama.296.1.56. JAMA. 2006. PMID: 16820547 Clinical Trial.
Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial.
Tonstad S, Tønnesen P, Hajek P, Williams KE, Billing CB, Reeves KR; Varenicline Phase 3 Study Group. Tonstad S, et al. JAMA. 2006 Jul 5;296(1):64-71. doi: 10.1001/jama.296.1.64. JAMA. 2006. PMID: 16820548 Clinical Trial.

Similar articles

The risk-benefit balance of varenicline for smoking cessation.
Hays JT. Hays JT. J Thorac Oncol. 2008 Sep;3(9):949-50. doi: 10.1097/JTO.0b013e31818593fc. J Thorac Oncol. 2008. PMID: 18758294 No abstract available.
Varenicline for smokeless tobacco dependence.
Aggarwal A, Jain M, Jiloha RC. Aggarwal A, et al. J Postgrad Med. 2010 Jan-Mar;56(1):50. doi: 10.4103/0022-3859.62414. J Postgrad Med. 2010. PMID: 20393259 No abstract available.
Smoking cessation therapy with varenicline.
Mohanasundaram UM, Chitkara R, Krishna G. Mohanasundaram UM, et al. Int J Chron Obstruct Pulmon Dis. 2008;3(2):239-51. doi: 10.2147/copd.s1848. Int J Chron Obstruct Pulmon Dis. 2008. PMID: 18686733 Free PMC article. Review.
Varenicline and smokers with mental illnesses.
Lasser KE, Boyd JW. Lasser KE, et al. Lancet. 2008 Oct 4;372(9645):1218-9. doi: 10.1016/S0140-6736(08)61513-5. Lancet. 2008. PMID: 19094948 No abstract available.
Varenicline use in patients with mental illness: an update of the evidence.
Purvis TL, Nelson LA, Mambourg SE. Purvis TL, et al. Expert Opin Drug Saf. 2010 May;9(3):471-82. doi: 10.1517/14740331003657133. Expert Opin Drug Saf. 2010. PMID: 20166836 Review.

See all similar articles

Cited by

α-Conotoxin TxID and [S9K]TxID, α3β4 nAChR Antagonists, Attenuate Expression and Reinstatement of Nicotine-Induced Conditioned Place Preference in Mice.
Li X, You S, Xiong J, Qiao Y, Yu J, Zhangsun D, Luo S. Li X, et al. Mar Drugs. 2020 Dec 16;18(12):646. doi: 10.3390/md18120646. Mar Drugs. 2020. PMID: 33339145 Free PMC article.
Varenicline for tobacco dependence: panacea or plight?
Williams JM, Steinberg MB, Steinberg ML, Gandhi KK, Ulpe R, Foulds J. Williams JM, et al. Expert Opin Pharmacother. 2011 Aug;12(11):1799-812. doi: 10.1517/14656566.2011.587121. Epub 2011 Jun 6. Expert Opin Pharmacother. 2011. PMID: 21644843 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information